Nucleoside phosphonate salts
US9006218B2 · kind B2 · utility
21Cited by
93References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2011 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Feb 14, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and methods for treating viral diseases. Some compounds of the invention are described by Formula I: (I), wherein M+ is Na+, Li+, K+, Ca2+, Mg2+, or NRcRdReRf+ and Rc, Rd, Re and Rf are each independently hydrogen or C1-5 alkyl, or a stereoisomer, a diastereomer, an enantiomer or racemate thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.